Compare PROK & MYFW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PROK | MYFW |
|---|---|---|
| Founded | 2015 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 316.0M | 312.1M |
| IPO Year | 2021 | 2018 |
| Metric | PROK | MYFW |
|---|---|---|
| Price | $1.92 | $31.56 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | $7.40 | ★ $27.00 |
| AVG Volume (30 Days) | ★ 1.1M | 39.8K |
| Earning Date | 05-08-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 54.02 |
| EPS | N/A | ★ 1.20 |
| Revenue | $893,000.00 | ★ $96,914,000.00 |
| Revenue This Year | N/A | $20.48 |
| Revenue Next Year | N/A | $9.70 |
| P/E Ratio | ★ N/A | $25.85 |
| Revenue Growth | ★ 1075.00 | 7.60 |
| 52 Week Low | $1.30 | $21.96 |
| 52 Week High | $3.48 | $34.36 |
| Indicator | PROK | MYFW |
|---|---|---|
| Relative Strength Index (RSI) | 69.27 | 52.67 |
| Support Level | $1.56 | $30.08 |
| Resistance Level | $2.22 | $32.59 |
| Average True Range (ATR) | 0.11 | 0.65 |
| MACD | 0.05 | 0.02 |
| Stochastic Oscillator | 100.00 | 61.88 |
ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.